InvestorsHub Logo

semi_infinite

11/04/22 11:45 AM

#244419 RE: dewophile #244418

Your ~2K for precomplexed afm13-cbNK is in agreement with company estimate on cHL. Pricing is same as CAR-T initially according to company per discussion with coverage specialists last year. Each billion cell dose current manufacturing cost is $1300 for cbNK portion. Don't have cost data on afm13 yet. In MDACC run trial, each patient at rp2d is getting around ~7B cells per cycle.